NCT04708184

A Study to Assess Relative Bioavailability of and Effect of Food on a New Oral Tablet Formulation of GLPG3970

A Randomized, Open-label, 3-period, Single-dose, Crossover Study in Healthy Adult Subjects to Assess the Relative Bioavailability of GLPG3970 Given as an Oral Tablet Formulation Versus the Oral Solution Formulation of GLPG3970 and to Assess the Effect of Food on the Oral Tablet Formulation.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: Galapagos NV · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This is a study to assess the relative bioavailability of a GLPG3970 oral tablet formulation compared to an oral solution formulation and the effect of food on the bioavailability of a single dose of the oral tablet formulation of GLPG3970. It will also evaluate the safety and tolerability of a single dose of GLPG3970.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	GLPG3970 oral solution	GLPG3970 for oral administration
DRUG	GLPG3970 tablet	GLPG3970 for oral administration

Timeline

• Start date: 2021-01-11
• Primary completion: 2021-02-25
• Completion: 2021-02-25
• First posted: 2021-01-13
• Last updated: 2021-03-25

Locations

1 site across 1 country: France